BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25633045)

  • 41. Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling.
    Gong JH; Zheng YB; Zhang MR; Wang YX; Yang SQ; Wang RH; Miao QF; Liu XJ; Zhen YS
    Cancer Biol Ther; 2020 Apr; 21(4):332-343. PubMed ID: 31906826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
    Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
    Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway.
    Liu J; Huang Y; Liu Y; Chen Y
    Med Sci Monit; 2019 Aug; 25():6085-6096. PubMed ID: 31412018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
    Yang C; Xu M; Shen HJ; Zhu HY; Li F; He M; Chen T; Wang J; Shi WJ; Ji F
    Int J Clin Exp Pathol; 2014; 7(2):521-8. PubMed ID: 24551272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer.
    Ahn DW; Seo JK; Lee SH; Hwang JH; Lee JK; Ryu JK; Kim YT; Yoon YB
    Pancreas; 2012 Oct; 41(7):1048-57. PubMed ID: 22513291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.
    Liu A; Chen H; Tong H; Ye S; Qiu M; Wang Z; Tan W; Liu J; Lin S
    Mol Med Rep; 2011; 4(2):221-7. PubMed ID: 21468555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
    Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
    J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer.
    Manu KA; Shanmugam MK; Ramachandran L; Li F; Siveen KS; Chinnathambi A; Zayed ME; Alharbi SA; Arfuso F; Kumar AP; Ahn KS; Sethi G
    Cancer Lett; 2015 Jul; 363(1):28-36. PubMed ID: 25827070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
    Yang Y; Tian W; Yang L; Zhang Q; Zhu M; Liu Y; Li J; Yang L; Liu J; Shen Y; Qi Z
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):93-103. PubMed ID: 32897433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q
    BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
    Wang W; Hu Z; Huang Y; Zheng H; Sun Q; Yang Q; Zhang Y; Zhang L; Wang W
    Biomed Res Int; 2019; 2019():9205851. PubMed ID: 31019975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway.
    Wang Y; Zhou Y; Jia G; Han B; Liu J; Teng Y; Lv J; Song Z; Li Y; Ji L; Pan S; Jiang H; Sun B
    Biochem Pharmacol; 2014 Apr; 88(3):322-33. PubMed ID: 24522113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H; Xie J; Peng J; Han Y; Jiang Q; Han M; Wang C
    Exp Cell Res; 2015 Mar; 332(2):236-46. PubMed ID: 25499970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D
    Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling.
    Qian Y; Yang B; Xiong Y; Gu M
    Oncol Rep; 2016 Sep; 36(3):1517-25. PubMed ID: 27459907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
    Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
    Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.
    Manu KA; Shanmugam MK; Li F; Chen L; Siveen KS; Ahn KS; Kumar AP; Sethi G
    J Mol Med (Berl); 2014 Mar; 92(3):267-76. PubMed ID: 24233024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness.
    Wattanawongdon W; Hahnvajanawong C; Namwat N; Kanchanawat S; Boonmars T; Jearanaikoon P; Leelayuwat C; Techasen A; Seubwai W
    Int J Oncol; 2015 Jul; 47(1):398-410. PubMed ID: 25998688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
    Ju HQ; Li H; Tian T; Lu YX; Bai L; Chen LZ; Sheng H; Mo HY; Zeng JB; Deng W; Chiao PJ; Xu RH
    J Pineal Res; 2016 Jan; 60(1):27-38. PubMed ID: 26445000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma.
    Kong X; Ma MZ; Zhang Y; Weng MZ; Gong W; Guo LQ; Zhang JX; Wang GD; Su Q; Quan ZW; Yang JR
    BMC Complement Altern Med; 2014 Jul; 14():254. PubMed ID: 25038821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.